Following tumor formation, M1 has an anti-tumor effect by direct tumor cytotoxic mechanisms or by facilitating the activity of CD8 cytotoxic T cells and NK cells to eliminate tumor cells during the advanced stages of colorectal cancer progression. The gene discussed is CD8A; the disease is neoplasm.